ANDARINE - Beligas Pharmaceuticals

First emerging in the early 2000s, Andarine (S4) is a SARM designed to provide anabolic effects similar to testosterone with reduced androgenic risks. It was developed by GTx Inc. for muscle-wasting conditions and prostate health, showing potential in increasing muscle mass and decreasing fat. Andarine’s mechanism of action involves selective binding to androgen receptors in skeletal muscle and bone, leading to strength gains without the common side effects of steroids. Despite promising trials, its development ceased, and it now circulates in the fitness community as a research chemical.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about ANDARINE by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.